Search > Results
You searched for: EV210239 (EV-TRACK ID)
Showing 1 - 3 of 3
Showing 1 - 3 of 3
Details | EV-TRACK ID | Experiment nr. | Species | Sample type | Separation protocol | First author | Year | EV-METRIC |
---|---|---|---|---|---|---|---|---|
EV210239 | 1/3 | Homo sapiens | Blood plasma | (d)(U)C | Marques FK | 2012 | 13% | |
Study summaryFull title
All authors
Marques FK, Campos FM, Filho OA, Carvalho AT, Dusse LM, Gomes KB
Journal
Clin Chim Acta
Abstract
The present study aimed to evaluate microparticles (MPs) from different sources in women with severe (show more...)
EV-METRIC
13% (30th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Blood plasma
Sample origin
Healthy non-pregnant
Focus vesicles
microparticle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Protein markers
EV: CD66/ CD51/ CD14/ CD41/ CD45/ CD235a/ CD3
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker
Sample
Species
Homo sapiens
Sample Type
Blood plasma
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 10,000 g and 50,000 g
Pelleting performed
Yes
Pelleting: time(min)
90
Pelleting: rotor type
Not specified
Pelleting: speed (g)
14000
Characterization: Protein analysis
Protein Concentration Method
Not determined
Flow cytometry aspecific beads
Antibody details provided?
Yes
Flow cytometry specific beads
Antibody details provided?
No
Antibody dilution provided?
No
Detected EV-associated proteins
CD66/ CD51/ CD14/ CD41/ CD45/ CD235a/ CD3
Characterization: Lipid analysis
No
|
||||||||
EV210239 | 2/3 | Homo sapiens | Blood plasma | (d)(U)C | Marques FK | 2012 | 13% | |
Study summaryFull title
All authors
Marques FK, Campos FM, Filho OA, Carvalho AT, Dusse LM, Gomes KB
Journal
Clin Chim Acta
Abstract
The present study aimed to evaluate microparticles (MPs) from different sources in women with severe (show more...)
EV-METRIC
13% (30th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Blood plasma
Sample origin
Healthy pregnant
Focus vesicles
microparticle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Protein markers
EV: CD66/ CD51/ CD14/ CD41/ CD45/ CD235a/ CD3
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker
Sample
Species
Homo sapiens
Sample Type
Blood plasma
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 10,000 g and 50,000 g
Pelleting performed
Yes
Pelleting: time(min)
90
Pelleting: rotor type
Not specified
Pelleting: speed (g)
14000
Characterization: Protein analysis
Protein Concentration Method
Not determined
Flow cytometry aspecific beads
Antibody details provided?
Yes
Flow cytometry specific beads
Antibody details provided?
No
Antibody dilution provided?
No
Detected EV-associated proteins
CD66/ CD51/ CD14/ CD41/ CD45/ CD235a/ CD3
Characterization: Lipid analysis
No
|
||||||||
EV210239 | 3/3 | Homo sapiens | Blood plasma | (d)(U)C | Marques FK | 2012 | 13% | |
Study summaryFull title
All authors
Marques FK, Campos FM, Filho OA, Carvalho AT, Dusse LM, Gomes KB
Journal
Clin Chim Acta
Abstract
The present study aimed to evaluate microparticles (MPs) from different sources in women with severe (show more...)
EV-METRIC
13% (30th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Blood plasma
Sample origin
Pregnant, severe preeclampsia
Focus vesicles
microparticle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Protein markers
EV: CD66/ CD51/ CD14/ CD41/ CD45/ CD235a/ CD3
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker
Sample
Species
Homo sapiens
Sample Type
Blood plasma
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 10,000 g and 50,000 g
Pelleting performed
Yes
Pelleting: time(min)
90
Pelleting: rotor type
Not specified
Pelleting: speed (g)
14000
Characterization: Protein analysis
Protein Concentration Method
Not determined
Flow cytometry aspecific beads
Antibody details provided?
Yes
Flow cytometry specific beads
Antibody details provided?
No
Antibody dilution provided?
No
Detected EV-associated proteins
CD66/ CD51/ CD14/ CD41/ CD45/ CD235a/ CD3
Characterization: Lipid analysis
No
|
||||||||
1 - 3 of 3 |
EV-TRACK ID | EV210239 | ||
---|---|---|---|
species | Homo sapiens | ||
sample type | Blood plasma | ||
condition | Healthy non-pregnant | Healthy pregnant | Pregnant severe preeclampsia |
separation protocol | dUC | dUC | dUC |
Exp. nr. | 1 | 2 | 3 |
EV-METRIC % | 13 | 13 | 13 |